Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”

Eric D. Bateman, Asif H. Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Paul Rowe, Heather Burnett, Jerome Msihid, David Weinreich, Ian D. Pavord

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number106088
JournalRespiratory Medicine
Volume191
DOIs
StatePublished - Jan 2022

Keywords

  • Benralizumab
  • Dupilumab
  • Indirect treatment comparison
  • Matching-adjusted indirect comparison
  • Mepolizumab
  • Severe eosinophilic asthma

Fingerprint

Dive into the research topics of 'Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”'. Together they form a unique fingerprint.

Cite this